Form 4: Zomedica COO, Anthony Blair, Executes Stock Transaction

Zomedica's Chief Operating Officer, Anthony Blair, acquired 150,000 shares and disposed of 400,000 shares of common stock in recent transactions.

Summary

• Anthony Blair, the Chief Operating Officer of Zomedica Corp., engaged in transactions involving the company's common stock.
• On November 8, 2024, Blair acquired 150,000 shares of common stock at a price of $0.123 per share.
• Following this acquisition, Blair disposed of 400,000 shares of common stock.
• The transactions were reported on November 12, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. These filings are closely watched by investors for insights into management's view of the company's prospects.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, and the information provided is consistent with what is expected in such filings.
• Similar filings can be seen from other companies such as PetMed Express (PETS) or IDEXX Laboratories (IDXX), where executives report their stock transactions.

Stakeholder Impact

• The stock transactions by the COO may be of interest to shareholders as it provides insight into management's trading activity.

Key Dates

Keywords

Zomedica, stock transaction, insider trading, common stock, Anthony Blair, COO